ArticleOPEN ACCESS

Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US (PharmacoEconomics, (2022), 40, 7, (699-714), 10.1007/s40273-022-01168-0)

PharmacoEconomics
DOI: 10.1007/s40273-023-01263-w
0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The following sentence was erroneously omitted from the Acknowledgements section of the article: The authors thank Alvin Ng, Alex Porteous, Faye Saville, Flo Anderson and Jennifer Page, employees of Costello Medical, Cambridge, UK, for deriving the US utility values employed in the analysis.

Cite

CITATION STYLE

APA

Goswami, H., Alsumali, A., Jiang, Y., Schindler, M., Duke, E. R., Cohen, J., … Puenpatom, A. (2023, May 1). Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US (PharmacoEconomics, (2022), 40, 7, (699-714), 10.1007/s40273-022-01168-0). PharmacoEconomics. Adis. https://doi.org/10.1007/s40273-023-01263-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free